Symbiotec Pharmalab: Promoter Pledge Re-created Post IPO Lock-in

Symbiotec Pharmalab Limited's promoter group has re-created a pledge on 4,50,896 equity shares (0.70% of total share capital) in favor of Beacon Trusteeship Limited. This action follows the release of an earlier pledge to facilitate the creation of a lock-in period on pre-issue shareholding as per SEBI ICDR Regulations, 2018, post the company's Initial Public Offer. The company states this is an administrative process with no effective change in the pledged holding. The re-creation of the pledge is linked to debentures issued under a Debenture Trust Deed.